Evidence map›Paper›PMID 30159430›Full record

ArticleNon-coding RNA research2017

The Y4-RNA fragment, a potential diagnostic marker, exists in saliva.

Tatsuya Ishikawa, Arisa Haino, Mineaki Seki, Hiroshi Terada, Masayuki Nashimoto

Open access · goldAbstract read
In one paragraph

Article in Non-coding RNA research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. TRUE Gene Silencing.International journal of molecular sciences · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tatsuya IshikawaResearch Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Niigata 956-8603, Japan.
Arisa HainoResearch Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Niigata 956-8603, Japan.
Mineaki SekiResearch Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Niigata 956-8603, Japan.
Hiroshi TeradaResearch Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Niigata 956-8603, Japan.
Masayuki NashimotoResearch Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Niigata 956-8603, Japan.
Niigata University of Pharmacy and Medical and Life Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 94-nt full-length Y4-RNA is thought to have roles in the initiation of DNA replication and RNA quality control. Although its 31/32-nt fragment also exists abundantly in plasma, little is known about its physiological role. Since the 31/32-nt Y4-RNA fragment in sera is reported to be more abundant in patients with coronary artery disease than healthy persons, the fragment may have a potential for a diagnostic and/or prognostic biomarker for some diseases regardless of its functionality. As a step toward further investigation of its potential utility, we examined if the 31/32-nt Y4-RNA fragment also exists in saliva that can be obtained noninvasively, and showed that, in addition to the 31/32-nt fragment, 14- and 11-nt Y4-RNA fragments are present in all saliva RNA samples from four healthy persons. We established a PCR method to accurately quantitate the amount of the 31/32-nt Y4-RNA fragment, and estimated its amount in saliva of healthy persons to be 0.06 ± 0.04 fmol per nanogram of saliva RNA. We also tried to develop an easier quantitation method using a DNA molecular beacon.

Indexed as

Diagnostic/prognostic markerMolecular beaconNext-generation sequencingRT-PCRSaliva RNAY4-RNA fragment

Identifiers

PMID30159430
PMCPMC6096425
OpenAlexW2736525774

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.